Acadia Pharmaceuticals
ACAD
ACAD
232 hedge funds and large institutions have $3.73B invested in Acadia Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 91 increasing their positions, 76 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
3% more capital invested
Capital invested by funds: $3.61B → $3.73B (+$121M)
3% less call options, than puts
Call options by funds: $41.1M | Put options by funds: $42.5M
Holders
232
Holding in Top 10
7
Calls
$41.1M
Puts
$42.5M
Top Buyers
| 1 | +$41.4M | |
| 2 | +$35.9M | |
| 3 | +$27.7M | |
| 4 |
Goldman Sachs
New York
|
+$26.9M |
| 5 |
State Street
Boston,
Massachusetts
|
+$26.5M |
Top Sellers
| 1 | -$32.6M | |
| 2 | -$12.6M | |
| 3 | -$8.01M | |
| 4 |
WC
Weatherbie Capital
Boston,
Massachusetts
|
-$7.44M |
| 5 |
FAM
Fred Alger Management
New York
|
-$6.61M |